000			01450 a2200445 4500
005			20250514000950.0
264		0	_c19990709
008			199907s 0 0 eng d
022			_a1058-7454
040			_aNLM _beng _cNLM
245	0	0	_aNew drugs in development. _h[electronic resource]
260			_bProject Inform perspective _cSep 1998
300			_a8 p. _bdigital
500			_aPublication Type: Newspaper Article; Journal Article
650	0	4	_aAdenine _xadverse effects
650	0	4	_aAlkynes
650	0	4	_aAnti-HIV Agents _xadverse effects
650	0	4	_aBenzoxazines
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aCarbamates
650	0	4	_aClinical Trials as Topic
650	0	4	_aCyclopropanes
650	0	4	_aDideoxynucleosides _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aDrugs, Investigational
650	0	4	_aFurans
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV Protease Inhibitors _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aImidazoles _xtherapeutic use
650	0	4	_aKidney Diseases _xchemically induced
650	0	4	_aLopinavir
650	0	4	_aOxazines _xtherapeutic use
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aPyrimidinones _xtherapeutic use
650	0	4	_aReverse Transcriptase Inhibitors _xtherapeutic use
650	0	4	_aSulfonamides _xtherapeutic use
650	0	4	_aViral Load
773	0		_tProject Inform perspective _gno. 25 _gp. 8
999			_c11297855 _d11297855